5 Best Biotech Stocks to Buy According to Joseph Edelman’s Perceptive Advisors

3. SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)

Edelman’s Stake Value: $399,681,000

Percentage of Joseph Edelman’s 13F Portfolio: 5.18%

Number of Hedge Fund Holders: 18

SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) is placed third on our list of the 10 best biotech stocks to buy according to Joseph Edelman’s Perceptive Advisors. Headquartered in Connecticut, SpringWorks is working towards developing and commercializing life-saving medicines for people with chronic illnesses. 

As per the latest data,  Perceptive Advisors owned 4.84 million shares in SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) at the end of the second quarter of 2021, worth $399.6 million.

As of the second quarter of 2021, the number of hedge fund positions in SpringWorks Therapeutics, Inc (NASDAQ: SWTX) declined to 18 in comparison to 22 positions in the preceding quarter.